TCTR20211115003招募中不适用
Immune response to the 3rd dose booster with mRNA-1273 COVID-19 vaccine in individuals who had received 2 doses of CoronaVac or ChAdOx-1 COVID-19 vaccine
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 N/A (No limit)（—）
- 性别
- All
入选标准
- •A healthy adults aged 18 years and older who had received either 2 doses of CoronaVac or ChAdOx-1 COVID vaccine.
排除标准
- •- Acute fever with body temperature above 38 degree Celsius on the day of vaccination.
- •- History of COVID-19 infection
- •- Get another vaccination no more than 2 weeks before enrollment.
- •- pregnant with a gestational age of less than 12 weeks
研究者
相似试验
进行中（未招募）
1 期
Assessment of effectiveness and safety of a 3rd dose of mRNA vaccine in kidney transplant recipients.SARS-CoV-2 infection in kidney transplant recipientssafety, effectiveness and immunogenicity of 3rd dose of SARS-CoV-2 mRNA vaccine.EUCTR2022-000319-30-CZInstitut Klinické a Experimentální Medicíny180
进行中（未招募）
不适用
Immunogenicity of the 3rd COVID-19 vaccine dose in Thai healthcare workers at Bamrasnaradura Infectious Diseases InstituteHealthcare workers who received two doses of SinovacCOVID-19 VaccineSARS-CoV-2AntibodyHealthcare WorkersAstraZenecaPfizerTCTR20211005001ational Research Council of Thailand (NRCT)170
招募中
2 期
Immunogenicity and safety of the third dose COVID-19 vaccine in Thai population.After the third dose of the COVID-19 vaccine, the immune response in healthy volunteers who received 2 doses of COVID19 vaccine (CoronaVac or ChAdOx1) at least three months.COVID-19 vaccine, Third dose, ChAdOx1, coronavac, Sinovac, BNT162b2, SinopharmTCTR20210731004Chulabhorn Royal Academy5,520
招募中
2 期
Immunogenicity and safety of the third dose COVID-19 vaccine via intradermal compare with intramuscular administration (Randomized controlled trial)The immune response after the third dose of the COVID-19 vaccine via intradermal administration in healthy volunteers.COVID-19 vaccine, Third dose, intradermal, ChAdOx1, coronavac, Sinovac, BNT162b2, mRNA1263, SinopharmTCTR20210731003Chulabhorn Royal Academy960
招募中
不适用
Pattern of antibody response after 3rd dose of COVID-19 vaccine booster among healthy volunteers.Healthy volunteerCOVID-19 Vaccinesadministration and dosageimmunologyTCTR20210831002akornping Hospital180